Navigation Links
Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast
Date:7/3/2008

SAN JUAN, Puerto Rico, July 3 /PRNewswire-FirstCall/ -- Triple-S Management Corporation (NYSE: GTS) today announced that the Company plans to release financial results for the second quarter ended June 30, 2008, before the market opens on August 5, 2008. Ramon M. Ruiz-Comas, President and Chief Executive Officer, and Juan-Jose Roman, Finance Vice President and Chief Financial Officer, will host a conference call to discuss these results and the outlook for the company at 10:00 a.m. Eastern Time.

To participate on the call, please dial 800-257-7087 or 303-262-2142 at least 5 minutes before start time. The conference call will also be simulcast live on the Internet, and can be accessed by logging onto http://www.triplesmanagement.com. In addition, a replay will be available through August 19, 2008 by calling 800-405-2236 or 303-590-3000 and entering passcode 11116721. A replay will also be available on the company's web site for 30 days.

About Triple-S Management Corporation

Triple-S Management Corporation is the largest managed care company in Puerto Rico and has the exclusive right to use the Blue Shield name and mark throughout the country. It holds a leading market position, with approximately 1 million members across all regions, or about 25 percent of the population. With more than 45 years of experience in the industry, Triple-S Management offers a broad portfolio of managed care and related products in the commercial, Medicare and the Reform markets. It also provides complementary products and services. The Company is the largest provider of life and accident and health insurance and the fourth largest provider of property and casualty insurance in its
'/>"/>

SOURCE Triple-S Management Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Triple-S Management Corporation Reports First Quarter 2008 Results; Cites Growth Resulting From Strong Market Position
2. Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast
3. Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
4. Triple-S Management Corporation to Present at UBS Global Healthcare Conference
5. Triple-S Management Corporation Announces Full Exercise of Underwriters Over-Allotment Option
6. Transition Therapeutics Announces Executive Management Appointments
7. BPO Management Services Wins Two New Information Technology Outsourcing Contracts
8. OneTouch(R) Ping(TM) Glucose Management System Cleared by FDA
9. China Improves Safety Management on Imported Foods in Preparation for Olympic Games
10. World's First USB Duplicator with Copy Protection and Digital Rights Management Available from Nexcopy and TrusCont Ltd.
11. Wound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...jury of 8 people in the Western District of Pennsy...pain and suffering for a medical malpractice case....ia Nocera of Thomas E. Crenney and Associates, LLC... Monestersky and against the Uniontown Hospital. ... hysterectomy at age 18. , ...
(Date:11/8/2009)...Newswire-USNewswire/ -- Pharmaceutical Research an...sident Ken Johnson released the following statemen..., "We are disappointed, but not surprised by toda...rdworking Americans as well as nearly half of the ...oted against the bill. ,, "While well intention...
(Date:11/8/2009)...ssage of Health Care Reform Bill ,, Critical ...erage for all Americans ,, BALTIMORE, Nov. 7 /...nited States House of Representatives passed criti...ngthen Medicare for seniors and end discrimination...ericans out of affordable health coverage. ,, T...
(Date:11/7/2009)...swire-USNewswire/ -- The American Medical Associat...f Health at the Family Violence Prevention Fund, w...t its semi-annual policy-making meeting. The Cita...r the AMA House of Delegates bestows on a non-phys...i-bin/prnh/20081209/AMALOGO ) ,, "Ms. James h...
(Date:11/7/2009)...holics have a responsibility to vigorously oppose ...uo." ,, WASHINGTON, Nov. 7 /PRNewswire-USNe...rown released the following statement on the news ...ancy Pelosi,s Affordable Health Care for America A...he status quo for abortion is voted upon. ,, "...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
... prescribed to lower cholesterol, may have protect...inic cohort study looked at three different aspect...tile dysfunction and prostate enlargement. Initial...al audio and video resources, including excerpts f...
...that outcomes of robotic assisted kidney cancer su...igh volume centers, prove more beneficial to patie...hored by Fox Chase robotic surgeon Rosalia Viterbo...ve the entire or a portion of the kidney. This is ...
...rts to cut back, , , SATURDAY, April 25 (H... the most important lifestyle changes people with ... the recommendation, a new study has found. , Res...e with heart failure is 2,000 milligrams, particip...
...astic Surgery increased too, with breast implants ..., bigger bank balances and stunning senior celebs ... April 25 A NEW trend in beauty has been seen by ...ving non-surgical treatments including Botox, derm...
...nsurance coverage affect their access to quality c...Cancer Center, insurance coverage may not only aff...e quality of care they receive. Research findings,...scovered a discrepancy in the type of surgical tre...
...tiple doctors who write prescriptions for drugs to...more on the importance of making sure that every d...sten to this report from Prescription Solutions at...xt, graphics and photos for free and unrestricted ...
Other Medicine News:Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 2Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 3Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 4Health News:Robotic assisted kidney cancer surgery proves to be beneficial to patients 2Health News:Hidden Salt in Diet Haunts Many With Heart Failure 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 3Health News:Does a person's insurance coverage affect their access to quality cancer care? 2
(Date:11/6/2009)....C., Nov. 6 Chimerix, Inc., a biop...ntiviral therapeutics to address life-threatening ...the company,s lead antiviral compound, CMX001, to ... Health Security Initiative (GHSI). CMX001 is a b...the treatment of smallpox, as well as other seriou...
(Date:11/6/2009)...re-FirstCall/ -- Caraco Pharmaceutical Laboratorie...tromethamine ophthalmic solution, 0.5% following a...ration (FDA) for Sun Pharma,s Abbreviated New Drug...lmic solution on the first day following patent ex...cally equivalent to Acular® Ophthalmic Soluti...
(Date:11/5/2009)...swire/ -- Althea Technologies, Inc., a leading pro...r biopharmaceutical products announced the additio...pany,s platform of services, which will be oversee...tor of Formulation Development. This investment in... scientists, along with new laboratory facilities ...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 1RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 1GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 1Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 2Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 4
...l Therapeutics (CTI),(Nasdaq and MTA: CTIC) announ...nd Drug Administration (FDA), CTI expects to begin...) and request priority review for pixantrone to tr...L) in the first quarter of 2009.,If granted priori... the end of,2009. , "This communication from t...
...t Angiolix has similar efficacy to Avastin alone a...th potentially less side-effects; study validates ...DALLAS, Jan. 26 ACCESS PHARMACEUTICALS, INC. (OTC...k on its proprietary humanized monoclonal antibody... with high affinity to the its target, lactadherin...
Other Medicine Technology:Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 2Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 3Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3
BUN (Urea Nitrogen)
Bilirubin Direct Reagent
...e is the first microplate spectrophotometer design...week. With rugged hardware, proven optical perform...arrier of traditional spectrophotometry to obtain ...rument can easily read up to eight, 1 cm Biocell c...
LS 45 Luminescence Spectrometer, 120V
Medicine Products: